Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Research for Resistance Factors in the Treatment of Lymphoid Hemopathy

NCT07385612

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHD Vendée La Roche-sur-Yon, France

CHU Nantes Nantes, France

CHU de Poitiers Poitiers, France

CH de Saint-Nazaire Saint-Nazaire, France

View Trial Details

Not Yet Recruiting

PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma

NCT07641010

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Xuzhou Children's Hospital Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

NCT07335328

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

NCT07575412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Digestive System Diseases, Follicular Grade 3 Lymphoma, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma

NCT07628595

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

NCT07636564

Conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT07634289

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Townsville University Hospital Douglas, Queensland, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Flinders Medical Centre Bedford Park, South Australia, Australia

Austin Hospital Heidelberg, Victoria, Australia

View Trial Details

Not Yet Recruiting

Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

NCT07634263

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations: Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark

Odense University Hospital Odense, Denmark

Sjællands Universitets Hospital Roskilde, Denmark

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions